EM1611F "Small Cell Lung Cancer – New Insights, Novel Therapeutics, Renewed Hope" (IM GR-111816)
The purpose of this presentation is to define current standards of care and future therapeutic research directions in the treatment of small cell lung cancer.
UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.
At the conclusion of this activity, the participant should be able to:
- Describe the current epidemiology of small cell lung cancer.
- Know the current standard of care for small cell lung cancer by stage of disease
- Be aware of the new molecular targets being currently explored for the treatment of small cell lung cancer
Charles M. Rudin, M.D., Ph.D.
Chief, Thoracic Oncology Service
Co-Director, Druckenmiller Center for Lung Cancer Research
Sylvia Hassenfeld Chair in Lung Cancer Research
Memorial Sloan Kettering Cancer Center, New York City, New York
Pamela Hearn Isom Visiting Lectureship Honoring Eugene P. Frenkel, M.D.
- 1.00 AMA
Activities should be run with recent versions of common browsers, including Internet Explorer, Firefox and Google Chrome